Protein kinase C-α and arginase I mediate pneumolysin-induced pulmonary endothelial hyperpermeability

American Journal of Respiratory Cell and Molecular Biology

Volumn 47, Issue 4, 2012, Pages 445-453

  Lucas, Rudolf ^a   Yang, Guang ^a   Gorshkov, Boris A ^a   Zemskov, Evgeny A ^a   Sridhar, Supriya ^a   Umapathy, Nagavedi S ^a   Jezierska Drutel, Agnieszka ^a,b   Alieva, Irina B ^a,c   Leustik, Martin ^d   Hossain, Hamid ^d   Fischer, Bernhard ^e   Catravas, John D ^a   Verin, Alexander D ^a   Pittet, Jean François ^f   Caldwell, Ruth B ^a   Mitchell, Timothy J ^g   Cederbaum, Stephen D ^h   Fulton, David J ^a   Matthay, Michael A ⁱ   Caldwell, Robert W ^a   Romero, Maritza J ^a   Chakraborty, Trinad ^d   more..

^a MEDICAL COLLEGE OF GEORGIA   (United States)

^b MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^c MOSCOW STATE UNIVERSITY   (Russian Federation)

^d JUSTUS LIEBIG UNIVERSITY   (Germany)

^e Baxter BioScience   (Austria)

^f UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^g UNIVERSITY OF BIRMINGHAM   (United Kingdom)

^h UNIVERSITY OF CALIFORNIA   (United States)

ⁱ UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Arginase; PKC; Pneumococcus; Pneumolysin; TNF

Indexed keywords

ARGINASE; ARGINASE 1; ARGINASE 2; MYOSIN LIGHT CHAIN; NITRIC OXIDE; PNEUMOLYSIN; PROTEIN KINASE C ALPHA; RAC1 PROTEIN; RHOA GUANINE NUCLEOTIDE BINDING PROTEIN; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CALCIUM TRANSPORT; CONTROLLED STUDY; ENDOTHELIAL DYSFUNCTION; ENDOTHELIUM CELL; ENZYME ACTIVATION; ENZYME ACTIVITY; HUMAN; HUMAN CELL; IN VITRO STUDY; LUNG DISEASE; MALE; MICROTUBULE; MICROVASCULAR ENDOTHELIAL CELL; MOUSE; NONHUMAN; PERMEABILITY; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; PULMONARY ARTERY; PULMONARY ARTERY ENDOTHELIAL CELL; PULMONARY ENDOTHELIAL HYPERPERMEABILITY; WILD TYPE;

ANIMALS; ANTIGENS, CD; ARGINASE; BACTERIAL PROTEINS; CADHERINS; CALCIUM SIGNALING; CAPILLARY PERMEABILITY; CELLS, CULTURED; ENDOTHELIAL CELLS; ENZYME INHIBITORS; HUMANS; LUNG; MALE; MICE; MICE, INBRED C57BL; MICROTUBULES; MICROVESSELS; PNEUMONIA; PROTEIN KINASE C-ALPHA; RHOA GTP-BINDING PROTEIN; STREPTOLYSINS;

MUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84866321884     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0332OC     Document Type: Article

References (50)

1. Rudan I, Boschi-Pinto C, Biloglav Z, Mulholland K, Campbell H. Epidemiology and etiology of childhood pneumonia. Bull World Health Organ 2008;86:408-416. (Pubitemid 351694322)
2. Waterer GW, Rello J, Wunderink RG. Management of community-acquired pneumonia in adults. Am J Respir Crit Care Med 2011;183:157-164.
3. Rubins JB, Charboneau D, Fasching C, Berry AM, Paton JC, Alexander JE, Andrew PW, Mitchell TJ, Janoff EN. Distinct roles for pneumolysin's cytotoxic and complement activities in the pathogenesis of pneumococcal pneumonia. Am J Respir Crit Care Med 1996;153:1339-1346. (Pubitemid 26112601)
4. Witzenrath M, Gutbier B, Hocke AC, Schmeck B, Hippenstiel S, Berger K, Mitchell TJ, de los Toyos JR, Rosseau S, Suttorp N, et al. Role of pneumolysin for the development of acute lung injury in pneumococcal pneumonia. Crit Care Med 2006;34:1947-1954. (Pubitemid 43982472)
5. Anderson R, Steel HC, Cockeran R, von Gottberg A, de Gouveia L, Klugman KP, Mitchell TJ, Feldman C. Comparison of the effects of macrolides, amoxicillin, ceftriaxone, doxycycline, tobramycin and fluoroquinolones, on the production of pneumolysin by Streptococcus pneumoniae in vitro. J Antimicrob Chemother 2007;60:1155-1158. (Pubitemid 47617770)
6. Maus UA, Srivastava M, Paton JC, Mack M, Everhart MB, Blackwell TS, Christman JW, Schlöndorff D, Seeger W, Lohmeyer J. Pneumolysin-induced lung injury is independent of leukocyte trafficking into the alveolar space. J Immunol 2004;173:1307-1312. (Pubitemid 38924309)
7. Stringaris AK, Geisenhainer J, Bergmann F, Balshüsemann C, Lee U, Zysk G, Mitchell TJ, Keller BU, Kuhnt U, Gerber J, et al. Neurotoxicity of pneumolysin, a major pneumococcal virulence factor, involves calcium influx and depends on activation of p38 mitogen-activated protein kinase. Neurobiol Dis 2002;11:355-368. (Pubitemid 36269122)
8. Sandoval R, Malik AB, Minshall RD, Kouklis P, Ellis CA, Tiruppathi C. Ca(2+) signalling and PKC-α activate increased endothelial permeability by disassembly of VE-cadherin junctions. J Physiol 2001;533:433-445. (Pubitemid 32519999)
9. Petrache I, Birukova A, Ramirez SI, Garcia JG, Verin AD. The role of the microtubules in tumor necrosis factor-alpha-induced endothelial cell permeability. Am J Respir Crit Care Med 2003;28:574-581. (Pubitemid 36543404)
10. Mehta D, Rahman A, Malik AB. Protein kinase C-alpha signals rho-guanine nucleotide dissociation inhibitor phosphorylation and Rho activation and regulates the endothelial cell barrier function. J Biol Chem 2001;276:22614-22620.
11. Cederbaum SD, Yu H, Grody WW, Kern RM, Yoo P, Iyer RK. Arginases I and II: do their functions overlap? Mol Genet Metab 2004;81:S38-S44. (Pubitemid 38402233)
12. Romero M, Platt D, Tawfik H, Labazi M, ElRemessy AB, Bartoli M, Caldwell RB, Caldwell RW. Diabetes-induced coronary vascular dysfunction involves increased arginase activity. Circ Res 2008;102:95-102.
13. Chandra S, Romero M, Shatanawi A, Alkilany A, Caldwell RB, Caldwell RW. Oxidative species increase arginase activity in endothelial cells through RhoA/Rho kinase pathway. Br J Pharmacol 2012;165:506-519.
14. Zhang C, Hein TW, Wang W, Chang CI, Kuo L. Constitutive expression of arginase in microvascular endothelial cells counteracts nitric oxide-mediated vasodilatory function. FASEB J 2001;15:1264-1266.
15. Chicoine LG, Paffett ML, Young TL, Nelin LD. Arginase inhibition increases nitric oxide production in bovine pulmonary arterial endothelial cells. Am J Physiol Lung Cell Mol Physiol 2004;287:L60-L68. (Pubitemid 38787651)
16. North ML, Khanna N, Marsden PA, Grasemann H, Scott JA. Functionally important role for arginase 1 in the airway hyperresponsiveness of asthma. Am J Physiol Lung Cell Mol Physiol 2009;296:L911-L920.
17. Xu W, Kaneko FT, Zheng S, Comhair SA, Janocha AJ, Goggans T, Thunnissen FB, Farver C, Hazen SL, Jennings C, et al. Increased arginase II and decreased NO synthesis in endothelial cells of patients with pulmonary arterial hypertension. FASEB J 2004;18:1746-1748. (Pubitemid 39561671)
18. Grasemann H, Schwiertz R, Matthiesen S, Racke K, Ratjen F. Increased arginase activity in cystic fibrosis airways. Am J Respir Crit Care Med 2005;172:1523-1528. (Pubitemid 43076540)
19. Deignan JL, Livesay JC, Yoo PK, Goodman SI, O'Brien WE, Iyer RK, Cederbaum SD, Grody WW. Ornithine deficiency in the arginase double knockout mouse. Mol Genet Metab 2006;89:87-96. (Pubitemid 44205470)
20. Diaz V, Brower R, Calfee CS, Matthay MA. Therapeutic strategies for severe acute lung injury. Crit Care Med 2010;38:1644-1650.
21. Elia N, Tapponnier M, Matthay MA, Hamacher J, Pache JC, Brundler MA, Totsch M, De Baetselier P, Fransen L, Fukuda N, et al. Functional identification of the alveolar edema reabsorption activity of murine tumor necrosis factor-alpha. Am J Respir Crit Care Med 2003;168:1043-1050. (Pubitemid 37338932)
22. Vadász I, Schermuly RT, Ghofrani HA, Rummel S, Wehner S, Mühldorfer I, Schäfer KP, Seeger W, Morty RE, Grimminger F, et al. The lectin-like domain of tumor necrosis factor-alpha improves alveolar fluid balance in injured isolated rabbit lungs. Crit Care Med 2008;36:1543-1550. (Pubitemid 351620646)
23. Hamacher J, Stammberger U, Roux J, Kumar S, Yang G, Xiong C, Schmid RA, Fakin RM, Chakraborty T, Hossain HM, et al. The lectin-like domain of TNF improves lung function after rat lung transplantation: potential role for a reduction in reactive oxygen species generation. Crit Care Med 2010;38:871-878.
24. Hazemi P, Tzotzos SJ, Fischer B, Andavan GS, Fischer H, Pietschmann H, Lucas R, Lemmens-Gruber R. Essential structural features of TNF-α lectin-like domain derived peptides for activation of amiloride-sensitive sodium current in A549 cells. J Med Chem 2011;53:8021-8029.
25. Hribar M, Bloc A, van der Goot FG, Fransen L, De Baetselier P, Grau GE, Bluethmann H, Matthay MA, Dunant Y, Pugin J, et al. The lectin-like domain of tumor necrosis factor-alpha increases membrane conductance in microvascular endothelial cells and peritoneal macrophages. Eur J Immunol 1999;29:3105-3111. (Pubitemid 29484200)
26. Kusche-Vihrog K, Sobczak K, Bangel N, Wilhelmi M, Nechyporuk-Zloy V, Schwab A, Schillers H, Oberleithner H. Aldosterone and amiloride alter ENaC abundance in vascular endothelium. Pflugers Arch 2008;455:849-857. (Pubitemid 350265623)
27. Wang S, Meng F, Mohan S, Champaneri B, Gu Y. Functional ENaC channels expressed in endothelial cells: a new candidate for mediating shear force. Microcirculation 2009;16:276-287.
28. Xiong C, Yang G, Kumar S, Aggarwal S, Leustik M, Snead C, Hamacher J, Fischer B, Umapathy NS, Hossain H, et al. The lectin-like domain of TNF protects from listeriolysin-induced hyperpermeability in human pulmonary microvascular endothelial cells: a crucial role for protein kinase C-alpha inhibition. Vascul Pharmacol 2010;52:207-213.
29. Alieva IB, Zemskov EA, Kireev II, Gorshkov BA, Wiseman DA, Black SM, Verin AD. Microtubules growth rate alteration in human endothelial cells. J Biomed Biotechnol 2010;2010:671536.
30. Catravas JD, Snead C, Dimitropoulou C, Chang AS, Lucas R, Verin AD, Black SM. Harvesting, identification and barrier function of human lung microvascular endothelial cells. Vascul Pharmacol 2010;52:175-181.
31. Boucek MM, Snyderman R. Calcium influx requirement for human neutrophil chemotaxis: inhibition by lanthanum chloride. Science 1976;193:905-907.
32. Dudek SM, Garcia JG. Cytoskeletal regulation of pulmonary vascular permeability. J Appl Physiol 2001;91:1487-1500. (Pubitemid 32900340)
33. Lucas R, Sridhar S, Rick FG, Gorshkov B, Umapathy NS, Yang G, Oseghale A, Verin AD, Matthay MA, Chakraborty T, et al. Agonist of growth hormone-releasing hormone reduces pneumolysin-induced pulmonary permeability edema. Proc Natl Acad Sci USA 2012;109:2084-2089.
34. Vandenbroucke E, Mehta D, Minshall R, Malik AB. Regulation of endothelial junctional permeability. Ann N Y Acad Sci 2008;1123:134-145. (Pubitemid 351431312)
35. Rubins JB, Charboneau D, Paton JC, Mitchell TJ, Andrew PW, Janoff EN. Dual function of pneumolysin in the early pathogenesis of murine pneumococcal pneumonia. J Clin Invest 1995;95:142-150.
36. Birukova AA, Smurova K, Birukov KG, Usatyuk P, Liu F, Kaibuchi K, Ricks-Cord A, Natarajan V, Alieva I, Garcia JG, et al. Microtubule disassembly induces cytoskeletal remodeling and lung vascular barrier dysfunction: role of Rho-dependent mechanisms. J Cell Physiol 2004;201:55-70. (Pubitemid 39187045)
37. Huang F, Subbaiah PV, Holian O, Zhang J, Johnson A, Gertzberg N, Lum H. Lysophosphatidylcholine increases endothelial permeability: role of PKCalpha and RhoA cross talk. Am J Physiol Lung Cell Mol Physiol 2005;289:L176-L185. (Pubitemid 41008899)
38. Waschke J, Baumgartner W, Adamson RH, Zeng M, Aktories K, Barth H, Wilde C, Curry FE, Drenckhahn D. Requirement of Rac activity for maintenance of capillary endothelial barrier properties. Am J Physiol Heart Circ Physiol 2004;286:H394-H401. (Pubitemid 38049505)
39. Iliev AI, Djannatian JR, Nau R, Mitchell TJ, Wouters FS. Cholesterol-dependent actin remodeling via RhoA and Rac1 activation by the Streptococcus pneumoniae toxin pneumolysin. Proc Natl Acad Sci USA 2007;104:2897-2902. (Pubitemid 46327975)
40. Iliev AI, Djannatian JR, Opazo F, Gerber J, Nau R, Mitchell TJ, Wouters FS. Rapid microtubule bundling and stabilization by the Streptococcus pneumoniae neurotoxin pneumolysin in a cholesterol-dependent, non-lytic and Src-kinase dependent manner inhibits intracellular trafficking. Mol Microbiol 2009;71:461-477.
41. Wojciak-Stothard B, Torondel B, Zhao L, Renné T, Leiper JM. Modulation of Rac1 activity by ADMA/DDAH regulates pulmonary endothelial barrier function. Mol Biol Cell 2009;20:33-42.
42. Predescu D, Predescu S, Shimizu J, Miyawaki-Shimizu K, Malik AB. Constitutive eNOS-derived nitric oxide is a determinant of endothelial junctional integrity. Am J Physiol Lung Cell Mol Physiol 2005;289:L371-L381. (Pubitemid 41192711)
43. Mundy AL, Dorrington KL. Inhibition of nitric oxide synthesis augments pulmonary oedema in isolated perfused rabbit lung. Br J Anaesth 2000;85:570-576.
44. Ogonowski AA, Kaesemeyer WH, Jin L, Ganapathy V, Leibach FH, Caldwell RW. Effects of NO donors and synthase agonists on endothelial cell uptake of L-Arg and superoxide production. Am J Physiol 2000;278:C136-C143. (Pubitemid 30101904)
45. Michell BJ, Chen Zp, Tiganis T, Stapleton D, Katsis F, Power DA, Sim AT, Kemp BE. Coordinated control of endothelial nitric-oxide synthase phosphorylation by protein kinase C and the cAMP-dependent protein kinase. J Biol Chem 2001;276:17625-17628.
46. Chicoine LG, Stenger MR, Cui H, Calvert A, Evans RJ, English BK, Liu Y, Nelin LD. Nitric oxide suppression of cellular proliferation depends on cationic amino acid transporter activity in cytokine-stimulated pulmonary endothelial cells. Am J Physiol Lung Cell Mol Physiol 2011;300:L596-L604.
47. Huynh NN, Harris EE, Chin-Dusting JF, Andrews KL. The vascular effects of different arginase inhibitors in rat isolated aorta and mesenteric arteries. Br J Pharmacol 2009;156:84-93.
48. Chen XJ, Seth S, Yue G, Kamat P, Compans RW, Guidot D, Brown LA, Eaton DC, Jain L. Influenza virus inhibits ENaC and lung fluid clearance. Am J Physiol Lung Cell Mol Physiol 2004;287:L366-L373. (Pubitemid 38943919)
49. Yang L, Qiao G, Ying H, Zhang J, Yin F. TCR-induced Akt serine 473 phosphorylation is regulated by protein kinase C-alpha. Biochem Biophys Res Commun 2010;400:16-20.
50. Gordon S. Alternative activation of macrophages. Nat Rev Immunol 2003;3:23-35. (Pubitemid 37328697)